Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
Aramark director Brian M. DelGhiaccio received an equity award of 5,124 deferred stock units of common stock on February 3, 2026 at $38.06 per unit. After this grant, he beneficially owns 16,301.732 common shares or equivalents on a direct basis.
The deferred stock units will vest the day before the first annual stockholders' meeting after the grant date, subject to continued board service, and will be settled in common shares on the first day of the seventh month after his departure from the board.
Aramark director Greg Creed reported a grant of 5,124 deferred stock units of common stock at $38.06 per share. Following this award on 02/03/2026, he beneficially owned 66,373.661 shares directly and 12,475 shares indirectly through a trust.
The deferred stock units will vest on the day before the first annual stockholders' meeting held after the grant date, subject to his continued board service. If vested, they will be settled in common shares on the first day of the seventh month after he leaves the board.
Aramark director Bridgette P. Heller received an award of 5,124 deferred stock units of common stock at a reference price of $38.06 per share. After this grant, she beneficially owns 35,637.088 shares directly. These deferred stock units vest the day before the first annual stockholders’ meeting following the grant, as long as she continues serving on the board.
If the award vests, it will be settled in Aramark common stock on the first day of the seventh month after she leaves the board, turning the deferred units into actual shares at that time.
Aramark director Patricia E. Lopez reported an equity award of 5,124 deferred stock units of common stock on February 3, 2026. The units are valued at $38.06 per share for reporting purposes, and her directly held beneficial ownership increased to 28,992.516 shares after this grant.
The deferred stock units will vest on the day before the first annual stockholders’ meeting of Aramark that occurs after the grant date, as long as she continues serving on the board. Once vested, they will be settled in Aramark common stock on the first day of the seventh month after she leaves the board.
Aramark reported the results of its 2026 Annual Meeting of Shareholders held on February 3, 2026. Shareholders elected 11 director nominees to the Board of Directors, each to serve until the 2027 Annual Meeting or until a successor is duly elected and qualified.
Shareholders also ratified the appointment of Deloitte & Touche LLP as Aramark’s independent registered public accounting firm for the fiscal year ending October 2, 2026, with 249,670,984 votes in favor. In addition, on an advisory basis, shareholders approved the compensation of the company’s named executive officers as disclosed in the proxy statement.
Aramark’s EVP and CFO, James J. Tarangelo, reported a tax-related share withholding tied to restricted stock units. On January 16, 2026, 1,141.457 shares of Aramark common stock were withheld at $39.01 per share to cover taxes due on the vesting of restricted stock units, rather than being sold in the open market.
After this withholding, Tarangelo directly beneficially owned 60,218.532 shares of Aramark common stock. The filing reflects an administrative equity and tax event, not a discretionary open-market purchase or sale.
Aramark director Richard W. Dreiling received a grant of 706 fully vested deferred stock units on January 9, 2026, tied to his decision to defer all of his cash board retainer. The units are valued at $38.93 per share equivalent and will be settled in shares of Aramark common stock on the first day of the seventh month after he leaves the board. Following this grant, he beneficially owns 8,697.184 shares of Aramark common stock directly.
Aramark director Greg Creed reported a routine equity compensation grant. On January 9, 2026, he received 866 fully vested deferred stock units, valued at $38.93 per share, in place of his cash board retainer. These units will be settled in Aramark common stock on the first day of the seventh month after he leaves the board.
Following this grant, Creed beneficially owned 61,249.661 shares of Aramark common stock directly. In addition, he had 12,475 shares reported as indirectly owned through a trust. The filing reflects compensation and holdings disclosure rather than a market sale.
Aramark executive Abigail Charpentier, EVP & Chief HR Officer, reported an automatic share withholding related to equity compensation. On January 6, 2026, 650.874 shares of common stock were withheld at $37.96 per share to cover taxes due upon the vesting of restricted stock units. After this tax withholding, Charpentier directly beneficially owned 80,671.639 shares of Aramark common stock. This transaction reflects routine tax settlement rather than an open‑market sale.
Aramark outlines strong 2025 performance and key voting items in its 2026 proxy statement. The company reports three-year compound annual growth rates of 11% for revenue and 24% for profitability, nearly $1 billion in net new business (5.6% of prior-year revenue), record gross new business of $1.6 billion (12% higher than prior year), and a client retention rate of 96.3%. Cash flow from operations rose 27% and free cash flow 41%, reducing the leverage ratio to 3.25x, the lowest since before going private in 2007. Aramark highlights broad deployment of AI across food production and supply chain and several large contract wins, including its largest U.S. contract with the University of Pennsylvania Health System. Shareholders are asked to elect 11 directors, ratify Deloitte & Touche LLP for fiscal 2026, and approve executive pay, after a 2025 annual bonus payout at 133% of target and PSU vesting at 89.1% of target.